Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)

SHE:301408 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	788.14	999.69	1,336	482.1	284.51	206.02
Short-Term Investments	-	-	-	-	-	20
Trading Asset Securities	275.63	10	12.41	-	0.5	5
Cash & Short-Term Investments	1,064	1,010	1,349	482.1	285.01	231.02
Cash Growth	-16.52%	-25.14%	179.76%	69.16%	23.37%	28.45%
Accounts Receivable	538.13	472.6	513.14	470.77	294.32	220.83
Other Receivables	45.64	44.12	36.24	34.52	30.82	27.07
Receivables	583.78	516.73	549.38	505.29	325.14	247.9
Inventory	927.42	863.84	772.09	545.01	436.19	302.96
Prepaid Expenses	-	15.63	8.27	2.52	4.22	63.48
Other Current Assets	162.91	191.49	147.78	165.22	62.74	79.31
Total Current Assets	2,738	2,597	2,826	1,700	1,113	924.68
Property, Plant & Equipment	948.7	967.8	870.15	533.42	542.53	49.62
Long-Term Investments	82.2	82.2	92.81	25.45	8.92	1.9
Goodwill	988.37	988.37	609.31	190.06	190.06	153.11
Other Intangible Assets	66.08	67.21	62.51	33	8.26	7.34
Long-Term Deferred Tax Assets	41.15	40.65	32.83	21.92	15.17	5.66
Long-Term Deferred Charges	61.52	59.03	52.11	58.97	92.32	126.04
Other Long-Term Assets	25.17	25.48	65.74	13.23	0.5	17.88
Total Assets	4,951	4,828	4,612	2,576	1,971	1,286
Accounts Payable	1,368	1,158	1,027	698.74	468.23	370.94
Accrued Expenses	52.73	140.25	99.84	101.68	79.98	61.32
Short-Term Debt	271.82	316.92	513.51	340.31	150.77	111.12
Current Portion of Long-Term Debt	383.65	116.02	10.25	-	-	-
Current Portion of Leases	-	210.44	193.64	154.24	144	-
Current Income Taxes Payable	37.31	20.63	12.3	34.63	13.15	4.87
Current Unearned Revenue	37.35	37.11	27.06	19.41	11.25	9.94
Other Current Liabilities	151.2	178.94	80.31	12.7	15.25	12.59
Total Current Liabilities	2,303	2,179	1,964	1,362	882.64	570.79
Long-Term Debt	307.09	358.83	331.15	18.95	-	-
Long-Term Leases	207.47	222.85	237.65	248.51	303.03	-
Long-Term Unearned Revenue	2.01	0.81	0.91	-	-	-
Long-Term Deferred Tax Liabilities	6.43	6.65	6.32	-	-	-
Other Long-Term Liabilities	-	-	95.4	-	0.33	0.38
Total Liabilities	2,826	2,768	2,635	1,629	1,186	571.17
Common Stock	400.01	400.01	400.01	340	340	340
Additional Paid-In Capital	977.86	977.86	1,014	194.7	192.99	192.75
Retained Earnings	688.64	627.42	529.39	412.58	251.81	182.08
Total Common Equity	2,067	2,005	1,944	947.28	784.8	714.83
Minority Interest	59.04	55.14	33	-0.27	0.25	0.24
Shareholders' Equity	2,126	2,060	1,977	947.01	785.05	715.07
Total Liabilities & Equity	4,951	4,828	4,612	2,576	1,971	1,286
Total Debt	1,170	1,225	1,286	762.02	597.8	111.12
Net Cash (Debt)	-106.26	-215.36	62.53	-279.92	-312.8	119.9
Net Cash Growth	-	-	-	-	-	495.88%
Net Cash Per Share	-0.26	-0.53	0.16	-0.82	-0.94	0.35
Filing Date Shares Outstanding	400.01	400.01	400.01	340	340	340
Total Common Shares Outstanding	400.01	400.01	400.01	340	340	340
Working Capital	435.37	418.84	862.52	338.42	230.65	353.89
Book Value Per Share	5.17	5.01	4.86	2.79	2.31	2.10
Tangible Book Value	1,012	949.71	1,272	724.22	586.49	554.38
Tangible Book Value Per Share	2.53	2.37	3.18	2.13	1.72	1.63
Buildings	-	219.2	238.73	23.15	23.15	23.15
Machinery	-	297.24	270.16	79.38	65.74	52.52
Construction In Progress	-	168.66	61.34	32.24	0.25	0.87

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.